TREATMENT OF THE HYPERMETABOLIC RESPONSE TO CNS INJURY
中枢神经系统损伤高代谢反应的治疗
基本信息
- 批准号:3847006
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The objective of this research is to improve outcome from a nuerological
injury by providing the optimal systemic environment for recovery of the
injured brain. Neurological injury causes systemic abnormalities that may
have adverse effects on neurological recovery. Hypermetabolism can
rapidly result in protein-calorie malnutrition, causing
immunoincompetence, multi-organ failure, and delayed healing of the
injury. Hyperglycemia, due to the systemic stress response, may worsen
the severity of lactic acidosis of the injured brain.
The first specific aim of the proposed project is to develop a method of
alimenting neurologically injured patients which will satisfy cerebral
and systemic protein and energy requirements without producing
hyperglycemia. A clinical trial will evaluate the use of triacetin and
1,3-butanediol as nonprotein caloric sources in head injured patients.
The effects of the feedings on both cerebral and systemic metabolism will
be evaluated.
The second specific aim is to determine if these metabolic and
physiological therapies will improve mortality after severe head injury.
The tird specific aim is to study the relationship of the systemic
hypermetabolism to the CNS inflammatory response to neurological injury.
These studies will be performed in association with a clinical trial of
the anti-inflammatory drugs, chloroquine and colchicine, as described in
detail in Project 4.
本研究的目的是改善神经病学的结果,
通过提供最佳的全身环境,
受伤的大脑神经损伤会导致全身异常,
对神经恢复有不良影响。代谢亢进可以
迅速导致蛋白质-热量营养不良,
免疫功能不全,多器官衰竭,和延迟愈合的
损伤由于全身性应激反应,高血压可能会恶化
受伤大脑乳酸酸中毒的严重程度。
拟议项目的第一个具体目标是开发一种方法,
为神经损伤患者提供营养,
和系统性蛋白质和能量需求,
高血糖症一项临床试验将评估三醋精的使用,
1,3-丁二醇作为脑损伤患者的非蛋白质热量来源。
喂养对大脑和全身代谢的影响将
被评价。
第二个具体目标是确定这些代谢和
生理疗法将改善严重脑损伤后的死亡率。
第三个具体目标是研究系统的关系,
高代谢导致中枢神经系统对神经损伤的炎症反应。
这些研究将与以下临床试验联合进行:
抗炎药氯喹和秋水仙碱,如
详细项目4
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT G GROSSMAN其他文献
ROBERT G GROSSMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT G GROSSMAN', 18)}}的其他基金
GENE THERAPY USING HSV TK GENE WITH ADMINISTRATION OF GANCICLOVIR IN ADULTS
使用 HSV TK 基因并给予成人更昔洛韦的基因治疗
- 批准号:
6306268 - 财政年份:1999
- 资助金额:
-- - 项目类别:
GENE THERAPY USING HSV TK GENE WITH ADMINISTRATION OF GANCICLOVIR IN ADULTS
使用 HSV TK 基因并给予成人更昔洛韦的基因治疗
- 批准号:
6116802 - 财政年份:1998
- 资助金额:
-- - 项目类别:
GENE THERAPY USING HSV TK GENE WITH ADMINISTRATION OF GANCICLOVIR IN ADULTS
使用 HSV TK 基因并给予成人更昔洛韦的基因治疗
- 批准号:
6278036 - 财政年份:1997
- 资助金额:
-- - 项目类别:
TREATMENT OF THE HYPERMETABOLIC RESPONSE TO CNS INJURY
中枢神经系统损伤高代谢反应的治疗
- 批准号:
3861608 - 财政年份:
- 资助金额:
-- - 项目类别:
AUTOTRANSPLANTATION OF ADRENAL MEDULLA TO BRAIN FOR PARKINSON'S TREATMENT
肾上腺髓质自体移植至大脑以治疗帕金森病
- 批准号:
3886101 - 财政年份:
- 资助金额:
-- - 项目类别:
TREATMENT OF THE HYPERMETABOLIC RESPONSE TO CNS INJURY
中枢神经系统损伤高代谢反应的治疗
- 批准号:
3902280 - 财政年份:
- 资助金额:
-- - 项目类别:
TREATMENT OF THE HYPERMETABOLIC RESPONSE TO CNS INJURY
中枢神经系统损伤高代谢反应的治疗
- 批准号:
3783080 - 财政年份:
- 资助金额:
-- - 项目类别:
TREATMENT OF THE HYPERMETABOLIC RESPONSE TO CNS INJURY
中枢神经系统损伤高代谢反应的治疗
- 批准号:
3882537 - 财政年份:
- 资助金额:
-- - 项目类别:
AUTOTRANSPLANTATION OF ADRENAL MEDULLA TO BRAIN FOR PARKINSON'S TREATMENT
肾上腺髓质自体移植至大脑以治疗帕金森病
- 批准号:
3905807 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Development of a humanised delivery system for interleukin 2 to treat traumatic brain injury
开发白细胞介素2人源化递送系统来治疗创伤性脑损伤
- 批准号:
MR/X029166/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Blood biomarkers to detect brain injury due to intimate partner violence
血液生物标志物可检测亲密伴侣暴力造成的脑损伤
- 批准号:
486950 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Targeting Ryanodine Receptor 2 for Treating Neonatal Hypoxic-ischemic Brain Injury (HIBI)
靶向 Ryanodine 受体 2 治疗新生儿缺氧缺血性脑损伤 (HIBI)
- 批准号:
488816 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Who is Caring for the Caregiver? Understanding Quality of Life and Mental Health Outcomes in Caregivers of Persons with Brain Injury
谁在照顾看护者?
- 批准号:
492369 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
A PROGRESS-Driven Approach to Cognitive Outcomes after Traumatic Brain Injury: Advancing Equity, Diversity, and Inclusion through Knowledge Synthesis and Mobilization
创伤性脑损伤后认知结果的进步驱动方法:通过知识合成和动员促进公平、多样性和包容性
- 批准号:
492338 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Advancing equity in traumatic brain injury care: A stakeholder-informed meeting on screening for traumatic brain injury in underserved populations
促进创伤性脑损伤护理的公平性:关于在服务不足的人群中筛查创伤性脑损伤的利益相关者知情会议
- 批准号:
487815 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Miscellaneous Programs
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
- 批准号:
10715238 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Monocyte-Derived Microglia in Development and after Neonatal Brain Injury
发育中和新生儿脑损伤后的单核细胞衍生的小胶质细胞
- 批准号:
10593385 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10573109 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




